NDC Package 71905-400-11 Dexabliss

View Billable Units, 11-Digit Format, RxNorm

Package Information
Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:

71905-400-11

Package Description:

39 TABLET in 1 DOSE PACK

Product Code:

71905-400

Proprietary Name:

Dexabliss

Usage Information:

Allergic states: Control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, and serum sickness.Dermatologic Diseases: Bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, and severe erythema multiforme (Stevens-Johnson syndrome).Endocrine Disorders: Primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; may be used in conjunction with synthetic mineralocorticoid analogs where applicable; In infancy mineralocorticoid supplementation is of particular importance), congenital adrenal hyperplasia, hypercalcemia associated with cancer, and nonsuppurative thyroiditis.Gastrointestinal Disease: To tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis.Hematologic Disorders: Acquired (autoimmune) hemolytic anemia, congenital (erythroid) hypoplastic anemia (Diamond-Blackfan anemia), idiopathic thrombocytopenic purpura in adults, pure red cell aplasia, and selected cases of secondary thrombocytopenia.Miscellaneous: Diagnostic testing of adrenocortical hyperfunction, trichinosis with neurologic or myocardial involvement, tuberculous meningitis with subarachnoid block or impending block when used with appropriate antituberculous chemotherapy.Neoplastic Disease: For the palliative management of leukemias and lymphomas.Nervous. System: Acute exacerbations of multiple sclerosis, cerebral edema associated with primary or metastatic brain tumor, craniotomy, or head injury.Ophthalmic Disease sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.Renal Diseases: To induce a diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus.Respiratory Diseases: Berylliosis, fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy, idiopathic eosinophilic pneumonias, symptomatic sarcoidosis.Rheumatic Disorders: As adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis, acute rheumatic carditis, ankylosing spondylitis, psoriatic arthritis, rheumatoid arthritis, including juvenile rheumatoid arthritis (selected cases may require low-dose maintenance therapy). For the treatment of dermatomyositis, polymyositis, and systemic lupus erythematosus.

11-Digit NDC Billing Format:

71905040011

Billing Unit:

EA - Billing unit of "each" is used when the product is dispensed in discreet units.

NDC to RxNorm Crosswalk:

39 EA

NDC to RxNorm Crosswalk:

RxCUI: 197580 - dexAMETHasone 1.5 MG Oral Tablet

RxCUI: 197580 - dexamethasone 1.5 MG Oral Tablet

RxCUI: 2121587 - {39 (dexamethasone 1.5 MG Oral Tablet) } Pack

RxCUI: 2121587 - dexAMETHasone 1.5 MG 39 Count 11-Day Pack

RxCUI: 2121587 - dexamethasone 1.5 MG Oral Tablet 39 Day Pack

Labeler Name:

Levins Pharmaceuticals, Llc

Sample Package:

Start Marketing Date:

04-09-2020

Listing Expiration Date:

12-31-2021

Exclude Flag:

Code Structure:

71905 - Levins Pharmaceuticals, Llc
- 71905-400 - Dexabliss
  - 71905-400-11 - 39 TABLET in 1 DOSE PACK

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 71905-400-11?

The NDC Packaged Code 71905-400-11 is assigned to a package of 39 tablet in 1 dose pack of Dexabliss, labeled by Levins Pharmaceuticals, Llc. The product's dosage form is and is administered via form.This product is billed for "EA" each discreet unit and contains an estimated amount of 39 billable units per package.

Is NDC 71905-400 included in the NDC Directory?

No, Dexabliss with product code 71905-400 is excluded from the NDC Directory because it's listing has been INACTIVATED by FDA. The product was first marketed by Levins Pharmaceuticals, Llc on April 09, 2020 and its listing in the NDC Directory is set to expire on December 31, 2021 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 71905-400-11?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 39.

What is the 11-digit format for NDC 71905-400-11?

The 11-digit format is 71905040011. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format	10-Digit Original Code	11-Digit Format	11-Digit Code
5-3-2	71905-400-11	5-4-2	71905-0400-11

Table of Contents